Nomura Holdings Inc Novo Cure LTD Transaction History

Nomura Holdings Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	SELL	$60.15 - $84.52 $308,990 - $434,179	-5,137 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $766,867 - $1.25 Million	-10,214 Reduced 66.54%	5,137 $386,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $1.04 Million - $1.75 Million	8,979 Added 140.91%	15,351 $1.78 Million
Q2 2021 Aug 16, 2021	SELL	$130.4 - $225.58 $1.23 Million - $2.13 Million	-9,450 Reduced 59.73%	6,372 $1.42 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $1.36 Million - $2.08 Million	10,922 Added 222.9%	15,822 $2.09 Million

Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $9.8 Million - $15.2 Million	-87,409 Reduced 94.69%	4,900 $849,000
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $4.87 Million - $9.34 Million	83,867 Added 993.45%	92,309 $10.3 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $657,456 - $855,268	-11,494 Reduced 57.65%	8,442 $499,000
Q1 2020 May 14, 2020	BUY	$57.05 - $95.75 $1.14 Million - $1.91 Million	19,936 New	19,936 $1.34 Million

291

74.5M

1.26M

247K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.19B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.